What is the significance of 3 squamous epithelial cells in a urinalysis for a menstruating female patient with leukocytosis, leukocyte esterase, bacteriuria, hematuria, proteinuria, and ketonuria?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Significance of 3 Squamous Epithelial Cells in Urinalysis

The finding of 3 squamous epithelial cells per low-power field in this menstruating female patient with multiple urinalysis abnormalities (leukocytosis, leukocyte esterase, bacteriuria, hematuria, proteinuria, ketonuria) indicates likely specimen contamination from vaginal/perineal sources, but does NOT rule out a true urinary tract infection given the constellation of other findings and clinical context.

Understanding Squamous Epithelial Cells

  • Squamous epithelial cells (SECs) originate from the distal urethra, vaginal mucosa, or perineal skin, not from the bladder or upper urinary tract 1
  • The presence of SECs is a poor predictor of urine culture contamination, with only 21% of midstream clean-catch samples with SECs showing actual bacterial contamination in women 1
  • SECs were present in 94% of catheterized samples from women with zero bacterial contamination, demonstrating that SECs alone do not indicate contamination 1
  • However, specimens with ≥10 SECs/mm³ had significantly more mixed growth (53% vs 22%) compared to specimens with <10 SECs/mm³ 2

Impact on Urinalysis Interpretation

  • The presence of SECs may reduce the predictive performance of traditional urinalysis measures for bacteriuria 3
  • Urinalysis samples with <8 SECs/lpf predicted bacteriuria better (sensitivity 75%, specificity 84%) than samples with >8 SECs/lpf (sensitivity 86%, specificity 70%) 3
  • The positive likelihood ratio for predicting bacteriuria drops from 4.98 in the absence of SECs to 2.35 when >8 SECs/lpf are present 3

Clinical Decision Algorithm for This Patient

Step 1: Assess for Specific UTI Symptoms

  • Look specifically for dysuria, frequency, urgency, fever >38°C, suprapubic pain, or new/worsening urinary incontinence 4
  • Do not attribute non-specific symptoms like confusion or functional decline to UTI without specific urinary symptoms 4
  • If the patient lacks specific urinary symptoms, do not pursue further UTI testing or treatment 4

Step 2: Consider Menstruation as a Confounding Factor

  • Menstruation is a recognized benign cause that should prompt repeat evaluation after the cause is excluded 5
  • Hematuria during menstruation requires microscopic confirmation after menstruation resolves before initiating referral 5
  • The American College of Physicians recommends up to 3 repeated analyses when menstruation, viral illness, or vigorous exercise is suspected 5

Step 3: Evaluate the Quality of Other Urinalysis Findings

  • The combination of positive leukocyte esterase with bacteriuria increases diagnostic accuracy substantially for UTI 4
  • Leukocyte esterase has moderate sensitivity (83%) but limited specificity (78%), improving to 93% sensitivity when combined with nitrite testing 4
  • The presence of proteinuria and ketonuria may indicate systemic illness or dehydration rather than isolated UTI 4

Step 4: Obtain Proper Specimen Collection

  • If strong clinical suspicion for UTI exists despite potential contamination, obtain a properly collected specimen before making treatment decisions 4
  • For women unable to provide clean specimens, in-and-out catheterization is recommended to avoid contamination 4
  • Process specimens within 1 hour at room temperature or 4 hours if refrigerated 4

Step 5: Culture Decision

  • If symptomatic with pyuria (≥10 WBCs/HPF or positive leukocyte esterase) AND acute onset of UTI-associated symptoms, obtain urine culture before starting antibiotics 4
  • Collect culture before initiating antimicrobial therapy to guide definitive therapy 4
  • Do not delay culture collection—always obtain culture before antibiotics in cases with significant pyuria 4

Critical Pitfalls to Avoid

  • Do not dismiss the entire urinalysis as contaminated based solely on the presence of 3 SECs, as this is a low count and SECs are poor predictors of contamination 1, 3
  • Do not treat based on urinalysis alone without confirming specific urinary symptoms 4
  • Do not assume all positive cultures represent infection—distinguish true UTI from asymptomatic bacteriuria, which has 10-50% prevalence in certain populations 4
  • Women have substantially lower rates of urology referral (8-28% vs 36-47% in men) and longer delays to evaluation despite presenting with more advanced disease, representing a critical disparity that should be avoided 5

Special Consideration for Hematuria

  • A threshold of at least 3 erythrocytes per HPF is considered abnormal and warrants evaluation 5
  • If menstruation is suspected as the cause of hematuria, repeat the evaluation after menstruation to document resolution 5
  • Women with hematuria typically present with more advanced bladder cancer and have higher case-fatality rates than men, making timely evaluation critical 5

References

Research

Urinary Squamous Epithelial Cells Do Not Accurately Predict Urine Culture Contamination, but May Predict Urinalysis Performance in Predicting Bacteriuria.

Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 2016

Guideline

Urinary Tract Infection Diagnosis and Evaluation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.